CALX vs. MNPR
CALX (Calix, Inc.) and MNPR (Monopar Therapeutics Inc.) are both stocks. CALX operates in Software - Application (Technology), while MNPR operates in Biotechnology (Healthcare). Over the past 5 years, CALX returned -5.16%/yr vs 32.48%/yr for MNPR. Their 0.12 correlation means their historical movements had little consistent relationship.
Performance
CALX vs. MNPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CALX achieves a -32.17% return, which is significantly lower than MNPR's 65.93% return.
CALX
- 1D
- 2.05%
- 1M
- -6.70%
- 6M
- -19.63%
- YTD
- -32.17%
- 1Y
- -35.96%
- 3Y*
- -6.68%
- 5Y*
- -5.16%
- 10Y*
- 16.84%
- ALL TIME*
- 4.68%
MNPR
- 1D
- -5.50%
- 1M
- 10.80%
- 6M
- 79.45%
- YTD
- 65.93%
- 1Y
- 166.28%
- 3Y*
- 210.34%
- 5Y*
- 32.48%
- 10Y*
- —
- ALL TIME*
- 15.51%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CALX Calix, Inc. | $66.73M | $55.05M | $45.28M |
| $36.50M | $30.07M | $17.88M |
CALX vs. MNPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
CALX Calix, Inc. | -32.17% | 51.79% | -20.19% | -36.15% | -14.43% | 168.72% | 272.00% | 0.50% |
MNPR Monopar Therapeutics Inc. | 65.93% | 196.82% | 1,193.36% | -85.65% | -26.17% | -47.55% | -63.13% | 98.80% |
Correlation
The correlation between CALX and MNPR is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.09 |
Correlation (3Y) Balances recent behavior with more history. | 0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Dec 19, 2019 | 0.12 |
Fundamentals
CALX:
$2.26B
MNPR:
$725.84M
CALX:
$0.77
MNPR:
-$524.02
CALX:
3.31
MNPR:
0.01
CALX:
$1.11B
MNPR:
$0.00
CALX:
$628.73M
MNPR:
$0.00
CALX:
$84.29M
MNPR:
-$5.24B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CALX vs. MNPR — Risk / Return Rank
CALX
MNPR
CALX vs. MNPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Calix, Inc. (CALX) and Monopar Therapeutics Inc. (MNPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CALX | MNPR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.02 | ||
| Sortino ratioReturn per unit of downside risk | -4.02 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.34 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.76 | 3.23 | -3.98 |
| Martin ratioReturn relative to average drawdown | -1.34 | 5.28 | -6.62 |
Loading charts...
Drawdowns
CALX vs. MNPR - Drawdown Comparison
The maximum CALX drawdown since its inception was -80.95%, smaller than the maximum MNPR drawdown of -98.93%. Use the drawdown chart below to compare losses from any high point for CALX and MNPR.
Loading charts...
Drawdown Indicators
| CALX | MNPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.95% | -98.93% | +17.98% |
Max Drawdown (1Y)Largest decline over 1 year | -48.58% | -50.89% | +2.31% |
Max Drawdown (3Y)Largest decline over 3 years | -48.58% | -67.26% | +18.68% |
Max Drawdown (5Y)Largest decline over 5 years | -65.32% | -95.18% | +29.86% |
Max Drawdown (10Y)Largest decline over 10 years | -65.32% | — | — |
Current DrawdownCurrent decline from peak | -55.11% | -19.74% | -35.37% |
Average DrawdownAverage peak-to-trough decline | -49.39% | -79.22% | +29.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.32% | 31.04% | -3.72% |
Volatility
CALX vs. MNPR - Volatility Comparison
The current volatility for Calix, Inc. (CALX) is 11.05%, while Monopar Therapeutics Inc. (MNPR) has a volatility of 19.37%. This indicates that CALX experiences smaller price fluctuations and is considered to be less risky than MNPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CALX | MNPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.05% | 19.37% | -8.32% |
Volatility (6M)Calculated over the trailing 6-month period | 30.45% | 48.14% | -17.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.02% | 78.06% | -38.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.82% | 296.13% | -247.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.33% | 275.24% | -223.91% |
Dividends
CALX vs. MNPR - Dividend Comparison
Neither CALX nor MNPR has paid dividends to shareholders.
Financials
CALX vs. MNPR - Financials Comparison
This section allows you to compare key financial metrics between Calix, Inc. and Monopar Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CALX and MNPR have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MNPR has higher volatility (19.37%) compared to CALX (11.05%). In terms of maximum drawdown, CALX dropped -80.95% vs MNPR's -98.93%.
MNPR currently has the higher Sharpe Ratio (2.11 vs -0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CALX and MNPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer